This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's
terms of use. It may require cleanup to comply with Wikipedia's
content policies, particularly
neutral point of view. (March 2024) |
Submission declined on 22 January 2024 by
Spinster300 (
talk). This submission does not appear to be written in
the formal tone expected of an encyclopedia article. Entries should be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
Submission declined on 6 November 2023 by
Vanderwaalforces (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Vanderwaalforces 7 months ago. |
Submission declined on 2 November 2023 by
CNMall41 (
talk). This submission appears to
read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's
verifiability policy and the
notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by
CNMall41 7 months ago. |
Submission declined on 13 July 2023 by
Ca (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Ca 10 months ago. |
Submission declined on 15 March 2023 by
Greenman (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Greenman 14 months ago. |
Adam Bierman | |
---|---|
Nationality | American |
Education | |
Known for | former CEO,
MedMen |
Adam Bierman is an American businessman and entrepreneur. [1] [2] He is best known for co-founding the cannabis retailer MedMen The Apple Store of Weed [3] [4] with partner Andrew Modlin, where he was CEO from 2010 until 2020. [5] [6]
Bierman was born in Scottsdale, Arizona. He attended Brandeis University in Waltham, Massachusetts for one year, then Los Angeles City College in order to pursue baseball more seriously. He transferred to USC, [7] dropping out shortly after the transfer went through to pursue his career building his sports agency. [8] [9]
In 2010, Bierman and Modlin had been running a branding, consulting, and construction firm in California when a dispensary owner, they call her the “blue-haired lady”, who was generating $300,000 a month and was looking for advice on how to double that. [10] [11]
In September 2012, the ModMan name was changed to MedMen and the DBA was filed. [12] Bierman’s exclusive trade became legal marijuana. [13] [14] [15] The licensing applications for medical dispensaries in Massachusetts opened in 2013 [16] and Bierman briefly did some consulting into the application process. [17] After realizing how the business model was moving forward in the cannabis industry, MedMen made the switch from consultancy to a management firm. [18] [19] [20] He also penned opinion articles on the cannabis industry for multiple outlets. [21] [22] [23] [2]
Over the next decade, Bierman grew MedMen to five states, [24] with a total of 33 retail stores, [25] and over 1,500 employees. It also became a publicly traded company [26] with a $1.65 billion market cap. [27] In January 2020, Bierman agreed to step down from his role as CEO of MedMen to assume a more strategic board position. [28] [29] [30]
In late 2018, MedMen signed a deal to acquire PharmaCann for $682 million, the largest acquisition in U.S. cannabis history. [31] Bill Barr and the Department of Justice opposed the deal and due to the dirty politics [32], the merger was terminated in October 2019. [33]
Bierman was able to secure millions in venture funding for MedMen. In April 2016, Cap-Meridian Ventures invested $15 million. [34] Two months later, Bierman launched Opportunity Fund I, which raised $60 million in 9 months. [35] The following year, Opportunity Fund II launched, securing $75 million in 6 months. [36]
Bierman continued to pursue investments into MedMen in 2018. In October, Bierman secured a loan for $94 million, [37] one of the first true senior secured loans in cannabis. A few days later, the loan increased to $100 million. [38]
In March 2019, Bierman helped MedMen secure a $250 million investment deal with Gotham Green Partners, [39] which raised an additional $30 million in July. [40] In December, Wicklow Partner also invested an additional $27 million. [41]
Bierman was the target of several allegations, ranging from mismanagement of money to personal biases. Most of these allegations arose out of a lawsuit in 2019 from former MedMen CFO Parker, [42] of which the jury found no proof, and ruled in favor of MedMen and Bierman. [43] In regards to this lawsuit, Bierman stated, “He clearly threw anything he could fabricate against the wall to see if it would stick. The problem is, as the jury found, none of it was true." [44]
In January 2019, Bierman and Modlin were subjects of a lawsuit from a shareholder entity in MedMen, claiming breach of fiduciary duty. [45] The lawsuit was dismissed in June of the same year. [46]
In 2022, Bierman was awarded a $3 million total in his lawsuit against MedMen for wrongful termination. [47]
This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's
terms of use. It may require cleanup to comply with Wikipedia's
content policies, particularly
neutral point of view. (March 2024) |
Submission declined on 22 January 2024 by
Spinster300 (
talk). This submission does not appear to be written in
the formal tone expected of an encyclopedia article. Entries should be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
Submission declined on 6 November 2023 by
Vanderwaalforces (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Vanderwaalforces 7 months ago. |
Submission declined on 2 November 2023 by
CNMall41 (
talk). This submission appears to
read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's
verifiability policy and the
notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by
CNMall41 7 months ago. |
Submission declined on 13 July 2023 by
Ca (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Ca 10 months ago. |
Submission declined on 15 March 2023 by
Greenman (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Greenman 14 months ago. |
Adam Bierman | |
---|---|
Nationality | American |
Education | |
Known for | former CEO,
MedMen |
Adam Bierman is an American businessman and entrepreneur. [1] [2] He is best known for co-founding the cannabis retailer MedMen The Apple Store of Weed [3] [4] with partner Andrew Modlin, where he was CEO from 2010 until 2020. [5] [6]
Bierman was born in Scottsdale, Arizona. He attended Brandeis University in Waltham, Massachusetts for one year, then Los Angeles City College in order to pursue baseball more seriously. He transferred to USC, [7] dropping out shortly after the transfer went through to pursue his career building his sports agency. [8] [9]
In 2010, Bierman and Modlin had been running a branding, consulting, and construction firm in California when a dispensary owner, they call her the “blue-haired lady”, who was generating $300,000 a month and was looking for advice on how to double that. [10] [11]
In September 2012, the ModMan name was changed to MedMen and the DBA was filed. [12] Bierman’s exclusive trade became legal marijuana. [13] [14] [15] The licensing applications for medical dispensaries in Massachusetts opened in 2013 [16] and Bierman briefly did some consulting into the application process. [17] After realizing how the business model was moving forward in the cannabis industry, MedMen made the switch from consultancy to a management firm. [18] [19] [20] He also penned opinion articles on the cannabis industry for multiple outlets. [21] [22] [23] [2]
Over the next decade, Bierman grew MedMen to five states, [24] with a total of 33 retail stores, [25] and over 1,500 employees. It also became a publicly traded company [26] with a $1.65 billion market cap. [27] In January 2020, Bierman agreed to step down from his role as CEO of MedMen to assume a more strategic board position. [28] [29] [30]
In late 2018, MedMen signed a deal to acquire PharmaCann for $682 million, the largest acquisition in U.S. cannabis history. [31] Bill Barr and the Department of Justice opposed the deal and due to the dirty politics [32], the merger was terminated in October 2019. [33]
Bierman was able to secure millions in venture funding for MedMen. In April 2016, Cap-Meridian Ventures invested $15 million. [34] Two months later, Bierman launched Opportunity Fund I, which raised $60 million in 9 months. [35] The following year, Opportunity Fund II launched, securing $75 million in 6 months. [36]
Bierman continued to pursue investments into MedMen in 2018. In October, Bierman secured a loan for $94 million, [37] one of the first true senior secured loans in cannabis. A few days later, the loan increased to $100 million. [38]
In March 2019, Bierman helped MedMen secure a $250 million investment deal with Gotham Green Partners, [39] which raised an additional $30 million in July. [40] In December, Wicklow Partner also invested an additional $27 million. [41]
Bierman was the target of several allegations, ranging from mismanagement of money to personal biases. Most of these allegations arose out of a lawsuit in 2019 from former MedMen CFO Parker, [42] of which the jury found no proof, and ruled in favor of MedMen and Bierman. [43] In regards to this lawsuit, Bierman stated, “He clearly threw anything he could fabricate against the wall to see if it would stick. The problem is, as the jury found, none of it was true." [44]
In January 2019, Bierman and Modlin were subjects of a lawsuit from a shareholder entity in MedMen, claiming breach of fiduciary duty. [45] The lawsuit was dismissed in June of the same year. [46]
In 2022, Bierman was awarded a $3 million total in his lawsuit against MedMen for wrongful termination. [47]